Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Income Statement
Earnings Waterfall
Aurinia Pharmaceuticals Inc
Revenue
|
175.5m
USD
|
Cost of Revenue
|
-14.1m
USD
|
Gross Profit
|
161.4m
USD
|
Operating Expenses
|
-253.1m
USD
|
Operating Income
|
-91.7m
USD
|
Other Expenses
|
13.7m
USD
|
Net Income
|
-78m
USD
|
Income Statement
Aurinia Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
-2%
|
1
-2%
|
1
-1%
|
0
-67%
|
0
-10%
|
0
-4%
|
0
-4%
|
0
-20%
|
0
+20%
|
0
N/A
|
0
-13%
|
0
-5%
|
0
-25%
|
0
+180%
|
0
N/A
|
0
-5%
|
0
+5%
|
0
-71%
|
0
+292%
|
1
+6%
|
0
-6%
|
0
N/A
|
0
-32%
|
0
-6%
|
0
+7%
|
0
N/A
|
0
-63%
|
50
+41 650%
|
51
+2%
|
58
+13%
|
72
+25%
|
46
-37%
|
66
+45%
|
88
+33%
|
129
+47%
|
134
+4%
|
147
+10%
|
160
+9%
|
159
-1%
|
176
+10%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(5)
|
(6)
|
(6)
|
(6)
|
(10)
|
(14)
|
|
Gross Profit |
1
N/A
|
1
-3%
|
1
-3%
|
1
-2%
|
0
-78%
|
0
+20%
|
0
N/A
|
0
N/A
|
0
-17%
|
0
+20%
|
0
-4%
|
0
-13%
|
0
N/A
|
0
-30%
|
0
+200%
|
0
N/A
|
0
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
7
+725%
|
22
+201%
|
45
+106%
|
65
+46%
|
85
+31%
|
124
+46%
|
128
+3%
|
141
+10%
|
154
+9%
|
149
-4%
|
161
+8%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(5)
|
(9)
|
(12)
|
(15)
|
(19)
|
(20)
|
(21)
|
(24)
|
(24)
|
(23)
|
(22)
|
(22)
|
(25)
|
(31)
|
(37)
|
(44)
|
(48)
|
(50)
|
(54)
|
(54)
|
(57)
|
(59)
|
(61)
|
(71)
|
(91)
|
(98)
|
(107)
|
(125)
|
(154)
|
(179)
|
(205)
|
(228)
|
(225)
|
(233)
|
(242)
|
(240)
|
(240)
|
(244)
|
(238)
|
(239)
|
(253)
|
|
Selling, General & Administrative |
(2)
|
(4)
|
(5)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(18)
|
(22)
|
(29)
|
(40)
|
(64)
|
(96)
|
(124)
|
(153)
|
(166)
|
(171)
|
(177)
|
(185)
|
(193)
|
(196)
|
(201)
|
(197)
|
(192)
|
(195)
|
|
Research & Development |
(2)
|
(3)
|
(5)
|
(7)
|
(9)
|
(11)
|
(13)
|
(15)
|
(16)
|
(16)
|
(14)
|
(13)
|
(15)
|
(19)
|
(23)
|
(31)
|
(34)
|
(36)
|
(39)
|
(39)
|
(41)
|
(43)
|
(44)
|
(50)
|
(53)
|
(56)
|
(56)
|
(50)
|
(50)
|
(46)
|
(45)
|
(53)
|
(51)
|
(54)
|
(55)
|
(46)
|
(45)
|
(46)
|
(47)
|
(49)
|
(50)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(15)
|
(11)
|
(10)
|
(9)
|
(7)
|
(7)
|
(6)
|
(7)
|
(1)
|
(0)
|
(1)
|
(0)
|
2
|
3
|
6
|
3
|
(8)
|
|
Operating Income |
(4)
N/A
|
(8)
-83%
|
(11)
-49%
|
(15)
-29%
|
(18)
-26%
|
(20)
-7%
|
(21)
-7%
|
(23)
-10%
|
(24)
-3%
|
(23)
+4%
|
(22)
+7%
|
(22)
0%
|
(24)
-13%
|
(31)
-26%
|
(36)
-18%
|
(44)
-20%
|
(48)
-9%
|
(50)
-4%
|
(54)
-8%
|
(54)
-1%
|
(56)
-5%
|
(58)
-3%
|
(61)
-5%
|
(71)
-16%
|
(91)
-28%
|
(97)
-7%
|
(107)
-10%
|
(125)
-17%
|
(104)
+17%
|
(128)
-23%
|
(148)
-16%
|
(156)
-5%
|
(181)
-16%
|
(168)
+7%
|
(157)
+7%
|
(116)
+26%
|
(112)
+4%
|
(103)
+7%
|
(83)
+19%
|
(90)
-8%
|
(92)
-2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
1
|
(5)
|
2
|
0
|
(3)
|
8
|
2
|
5
|
9
|
5
|
3
|
2
|
(40)
|
(33)
|
(31)
|
(23)
|
15
|
6
|
1
|
(8)
|
(3)
|
(0)
|
9
|
3
|
(40)
|
(41)
|
(46)
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
5
|
9
|
12
|
14
|
14
|
|
Non-Reccuring Items |
(2)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(7)
N/A
|
(11)
-61%
|
(21)
-95%
|
(15)
+28%
|
(19)
-31%
|
(23)
-20%
|
(13)
+44%
|
(21)
-62%
|
(19)
+11%
|
(14)
+23%
|
(17)
-18%
|
(19)
-13%
|
(23)
-22%
|
(71)
-205%
|
(70)
+1%
|
(76)
-8%
|
(71)
+7%
|
(34)
+52%
|
(48)
-39%
|
(53)
-11%
|
(64)
-21%
|
(61)
+5%
|
(61)
0%
|
(62)
-1%
|
(88)
-43%
|
(137)
-56%
|
(148)
-8%
|
(171)
-16%
|
(103)
+40%
|
(127)
-24%
|
(147)
-16%
|
(156)
-5%
|
(180)
-16%
|
(167)
+7%
|
(156)
+7%
|
(114)
+27%
|
(106)
+6%
|
(95)
+11%
|
(71)
+25%
|
(76)
-7%
|
(77)
-2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
4
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(3)
|
(7)
|
(17)
|
(15)
|
(19)
|
(23)
|
(13)
|
(21)
|
(19)
|
(14)
|
(17)
|
(19)
|
(23)
|
(71)
|
(70)
|
(76)
|
(71)
|
(34)
|
(48)
|
(53)
|
(64)
|
(61)
|
(61)
|
(62)
|
(88)
|
(137)
|
(148)
|
(171)
|
(103)
|
(127)
|
(148)
|
(156)
|
(181)
|
(168)
|
(157)
|
(115)
|
(108)
|
(97)
|
(73)
|
(77)
|
(78)
|
|
Net Income (Common) |
(3)
N/A
|
(7)
-149%
|
(17)
-151%
|
(15)
+12%
|
(19)
-31%
|
(23)
-20%
|
(13)
+44%
|
(21)
-62%
|
(19)
+11%
|
(14)
+23%
|
(17)
-18%
|
(19)
-13%
|
(23)
-22%
|
(71)
-205%
|
(70)
+1%
|
(76)
-8%
|
(71)
+7%
|
(34)
+52%
|
(48)
-39%
|
(53)
-11%
|
(64)
-21%
|
(61)
+5%
|
(61)
0%
|
(62)
-1%
|
(88)
-43%
|
(137)
-55%
|
(148)
-8%
|
(171)
-16%
|
(103)
+40%
|
(127)
-24%
|
(148)
-16%
|
(156)
-6%
|
(181)
-16%
|
(168)
+7%
|
(157)
+7%
|
(115)
+26%
|
(108)
+6%
|
(97)
+11%
|
(73)
+25%
|
(77)
-6%
|
(78)
-1%
|
|
EPS (Diluted) |
-0.21
N/A
|
-0.3
-43%
|
-0.53
-77%
|
-0.44
+17%
|
-0.67
-52%
|
-0.72
-7%
|
-0.42
+42%
|
-0.66
-57%
|
-0.58
+12%
|
-0.43
+26%
|
-0.51
-19%
|
-0.52
-2%
|
-0.66
-27%
|
-1.25
-89%
|
-0.84
+33%
|
-0.9
-7%
|
-0.92
-2%
|
-0.41
+55%
|
-0.57
-39%
|
-0.62
-9%
|
-0.76
-23%
|
-0.67
+12%
|
-0.66
+1%
|
-0.69
-5%
|
-0.95
-38%
|
-1.22
-28%
|
-1.31
-7%
|
-1.39
-6%
|
-0.87
+37%
|
-0.99
-14%
|
-1.17
-18%
|
-1.22
-4%
|
-1.4
-15%
|
-1.18
+16%
|
-1.1
+7%
|
-0.83
+25%
|
-0.76
+8%
|
-0.67
+12%
|
-0.5
+25%
|
-0.53
-6%
|
-0.54
-2%
|